Squarepoint’s Sanara MedTech SMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.27M Sell
53,811
-19,796
-27% -$409K ﹤0.01% 2712
2026
Q1
$1.26M Buy
73,607
+24,654
+50% +$507K ﹤0.01% 2573
2025
Q4
$1.14M Buy
48,953
+17,570
+56% +$454K ﹤0.01% 2491
2025
Q3
$996K Buy
31,383
+24,305
+343% +$734K ﹤0.01% 2696
2025
Q2
$201K Sell
7,078
-8,560
-55% -$257K ﹤0.01% 3980
2025
Q1
$483K Buy
15,638
+816
+6% +$27.7K ﹤0.01% 3334
2024
Q4
$492K Buy
14,822
+1,294
+10% +$43.9K ﹤0.01% 3733
2024
Q3
$409K Buy
+13,528
New +$422K ﹤0.01% 3252

Other funds holding SMTI

Squarepoint's SMTI Position: Q2 2026 in Review

Squarepoint reduced its Sanara MedTech (SMTI) stake by 27% in Q2 2026, selling an estimated $409K and leaving 53,811 shares worth $1.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2712.

Squarepoint first reported a position in SMTI in Q3 2024 and has held it in 8 quarters since. 74 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Squarepoint held 53,811 shares of Sanara MedTech worth $1.27M as of Q2 2026.
  • Squarepoint sold 19,796 Sanara MedTech shares in Q2 2026, an estimated $409K.
  • Sanara MedTech made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2712 holding.
  • Squarepoint first reported a position in Sanara MedTech in Q3 2024 and has held it in 8 quarters since.
  • 74 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.